Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Castle Biosciences Insider Sold Shares Worth $317,112, According to a Recent SEC Filing

Castle Biosciences Insider Sold Shares Worth $317,112, According to a Recent SEC Filing

MT newswireMT newswire2026/08/27 20:42
04:42 PM EDT, 08/27/2026 (MT Newswires) -- Tobin W Juvenal, Chief Commercial Officer, on August 25, 2026, sold 9,050 shares in Castle Biosciences (CSTL) for $317,112. Following the Form 4 filing with the SEC, Juvenal has control over a total of 66,914 common shares of the company, with 66,914 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1447362/000162828026059272/xslF345X05/wk-form4_1787863108.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BTC surpasses $78,000

金色财经2026/08/31 00:40

AON plans to acquire USI for 17 billion USD, aiming at the SME insurance brokerage market.

According to informed sources, AON.US is close to reaching a deal valued at around $17 billion, including debt, to acquire insurance brokerage USI from private equity firm KKR.

智通财经2026/08/31 00:16
AON plans to acquire USI for 17 billion USD, aiming at the SME insurance brokerage market.